ABT-620
Showing 1 - 25 of 387
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix
- +4 more
- (no location specified)
Jul 9, 2021
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix placebo
- +4 more
- (no location specified)
Jul 7, 2020
Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix
Active, not recruiting
- Endometriosis
- 75 mg linzagolix tablet
- +5 more
-
Dothan, Alabama
- +46 more
Jan 12, 2023
Assess Patient-Reported Quality of Life and Effectiveness on
Recruiting
- Heavy Menstrual Bleeding
- Uterine Fibroids
-
Durham, North CarolinaIQVIA RDS, Inc
Nov 2, 2021
Oral Elagolix Tablets To Assess Tolerability and Change in
Recruiting
- Endometriosis
-
Ramat Gan, Tel-Aviv, Israel
- +7 more
Jun 8, 2022
Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)
Active, not recruiting
- Heavy Menstrual Bleeding
- Uterine Fibroids
- Elagolix Placebo
- +3 more
-
Birmingham, Alabama
- +156 more
Jan 20, 2022
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +104 more
Jul 9, 2021
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
-
Birmingham, AlabamaA. Brent Carter
Aug 3, 2023
Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Bowel Trial in Vancouver (Transcutaneous Spinal Cord Stimulation, SHAM
Recruiting
- Spinal Cord Injuries
- +2 more
- Transcutaneous Spinal Cord Stimulation
- +2 more
-
Vancouver, British Columbia, CanadaBlusson Spinal Cord Centre
Nov 21, 2022
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Estradiol/Norethindrone Acetate
- Elagolix
-
Birmingham, Alabama
- +123 more
Jul 9, 2021
Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)
Suspended
- Chronic Spontaneous Urticaria
- ABT Online Programme
- Delayed Control group
-
Dublin, IrelandSt James's Hospital
Oct 25, 2023
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Sep 14, 2022
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Osteoarthritis of Hip Trial in Oswestry (Bioguard Group, Control Group)
Active, not recruiting
- Osteoarthritis of Hip
- Bioguard Group
- Control Group
-
Oswestry, United KingdomRJAH
Jan 24, 2023
Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)
Active, not recruiting
- Rheumatoid Arthritis
- Placebo for Adalimumab
- +3 more
-
Birmingham, Alabama
- +369 more
Jun 14, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +5 more
-
Greenwich, Connecticut
- +27 more
Dec 30, 2022
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021